Learnings from the RAS-Targeted Therapeutics Clinical Trials of Sotorasib
Time: 9:00 am
day: Day Two
Details:
• Showcasing where the approved KRAS inhibitors are today and how they get there
• Reviewing learnings from the sotorasib development journey
• Exploring what the future of monotherapies and combination regimes hold
